PD-1 inhibitor
![FDA Delay Coherus' Approvals for PD-1 Inhibitor and Neulasta Biosimilar Injector](https://pharmtales.com/wp-content/uploads/2023/09/FDA-Delay-Coherus-Approvals-for-PD-1-Inhibitor-and-Neulasta-Biosimilar-Injector.jpg)
FDA Delay Coherus’ Approvals for PD-1 Inhibitor and Neulasta Biosimilar Injector
Anika Sharma
Coherus BioSciences has experienced a challenging journey in seeking FDA approval for its PD-1 inhibitor, toripalimab, developed in partnership with ...